Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue (Q43237616)
Jump to navigation
Jump to search
scientific article published in December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue |
scientific article published in December 2009 |
Statements
1 reference
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue (English)
1 reference
D R Matthews
1 reference
J Jendle
1 reference
M A Nauck
1 reference
A Frid
1 reference
K Hermansen
1 reference
M Düring
1 reference
M Zdravkovic
1 reference
B J Strauss
1 reference
A J Garber
1 reference
LEAD-2 and LEAD-3 Study Groups
1 reference
1 December 2009
1 reference
1 reference
Identifiers
1 reference